Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Innospec Inc.NASDAQ: IOSP
Operating Income · Q2 FY2026 · quarter ended Jun 2026
Operating income growth accelerates
Q2 FY2026 operating income of $39.7M rose 15.7% year over year, ahead of the -8.4% change in trailing-twelve-month operating income. Sequentially, it rose 24.8% from the prior quarter. Over 3 fiscal years it compounded at -5.9% a year.
Context
- Operating income amounted to 8.8% of revenue in FY2025, down 0.8 pp from a year earlier.
- Operating income increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether operating income reaches the consensus estimate from 2 analysts of $160.65M (+2.8%) for the fiscal year ending Dec 2026, a step up from the -12.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $39.7M+24.8% QoQ
- Last fiscal yearDec 2025
- $156.3M-12.1% YoY
- LTMJun 2026
- $149.7M-8.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +15.7% | +27.9% | +12.1 pp |
| 1 year | -12.1% | +2.8% | +14.9 pp |
| 3-year CAGR | -5.9% | +11.2% | +17.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- 156.3M USD
- Year-over-year change
- -12.1%
- 4-year CAGR
- +4.3%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 156.3M | -12.1% |
| FY2024 | 2024-12-31 | 177.9M | +10.1% |
| FY2023 | 2023-12-31 | 161.6M | -13.7% |
| FY2022 | 2022-12-31 | 187.3M | +41.8% |
| FY2021 | 2021-12-31 | 132.1M | — |
Operating Income vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's LTM Jun 2026 operating income of $149.7M is the 7th highest of the 10 companies compared; the peer median is $179.2M.
- Its year-over-year change of -8.4% is the 5th highest of 10, against a peer median of -8.5%.
- Operating income amounts to 8.1% of revenue for IOSP, versus a peer median of 10.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $834M | -37.6% | -4.9% | 9.4% | |
| LTM Jun 2026 | $547.6M | -9.5% | +15.3% | 20.0% | |
| LTM Jun 2026 | $501M | -21.0% | +16.9% | 13.8% | |
| LTM Aug 2026 | $409.65M | +16.4% | +7.4% | 11.5% | |
| LTM Sep 2026 | $179.2M | -8.5% | -25.7% | 3.4% | |
| LTM Sep 2026 | $173.78M | +197.0% | +50.1% | 8.6% | |
| LTM Jun 2026 | $149.7M | -8.4% | -5.9% | 8.1% | |
| LTM Jun 2026 | $135M | +51.7% | — | 7.3% | |
| LTM Sep 2026 | $121.47M | +0.8% | +9.3% | 10.7% | |
| LTM Mar 2026 | -$43.88M | -190.2% | — | 39.8% | |
| Peer median (excluding IOSP) | $179.2M | -8.5% | +9.3% | 10.7% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.48B | 1.96B | 1.95B | 1.85B | 1.78B |
| Cost of Revenue | 1.05B | 1.38B | 1.36B | 1.3B | 1.29B |
| Gross Profit | 434.9M | 586.7M | 591.1M | 542.9M | 492.4M |
| Gross Margin | 29.3% | 29.9% | 30.3% | 29.4% | 27.7% |
| Research & Development | 37.4M | 38.7M | 41.7M | 47.8M | 51M |
| Selling, General & Admin | 267.2M | 360.7M | 387.8M | 314M | 285.1M |
| Operating Expenses | 302.8M | 399.4M | 429.5M | 365M | 336.1M |
| Depreciation & Amortization | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M |
| EBITDA | 173M | 225.8M | 213.7M | 224.6M | 181.7M |
| EBITDA Margin | 11.7% | 11.5% | 11.0% | 12.2% | 10.2% |
| Operating Income | 132.1M | 187.3M | 161.6M | 177.9M | 156.3M |
| Operating Margin | 8.9% | 9.5% | 8.3% | 9.6% | 8.8% |
| Interest Income | 0 | 0 | 0 | 0 | 9.2M |
| Interest Expense | 1.5M | 1.1M | 0 | 0 | 0 |
| Other Income / Expenses | 2.3M | (2.7M) | 12.8M | (136.7M) | (18.2M) |
| Income Before Tax | 134.4M | 184.6M | 174.4M | 41.2M | 138.1M |
| Pre-Tax Margin | 9.1% | 9.4% | 8.9% | 2.2% | 7.8% |
| Income Tax Expense | 41.3M | 51.6M | 35.3M | 5.6M | 21.5M |
| Net Income | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Net Margin | 6.3% | 6.8% | 7.1% | 1.9% | 6.6% |
| EPS (Basic) | 3.78 | 5.37 | 5.60 | 1.43 | 4.69 |
| EPS (Diluted) | 3.75 | 5.32 | 5.56 | 1.42 | 4.67 |
| Weighted Avg Shares | 24.65M | 24.79M | 24.85M | 24.93M | 24.88M |
| Weighted Avg Shares (Diluted) | 24.85M | 24.98M | 25.02M | 25.12M | 24.99M |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.